dr. john mascarenhas, md - pv moving beyond hydroxyurea
Published 6 years ago • 1.4K plays • Length 33:02Download video MP4
Download video MP3
Similar videos
-
40:09
new drugs for mpns - dr. john mascarenhas
-
3:23
mpn hero dr. john mascarenhas: dedicated researcher and clinician
-
2:47
mpn research and optimism about curative therapies
-
1:28
dr. mascarenhas on the mpd-rc 112 study in pv and essential thrombocythemia
-
3:52
dr mascarenhas discusses mds/mpn overlap for patients
-
4:59
john mascarenhas, md, ms: continuing to evaluate pacritinib for myelofibrosis
-
2:00
dr. mascarenhas on approved and emerging treatment options in myelofibrosis
-
2:45
what to expect when starting mpn inhibitor therapy
-
14:44
kau mascarenhas - "finja até conseguir"
-
13:27
myelin oligodendrocyte glycoprotein antibody-associated disease (mogad)
-
1:40
what is personalized medicine for et, pv & mf?
-
27:27
dr steven lane-new drugs for mpns evolving in aml
-
0:56
john mascarenhas, md, on the individualized management of myeloproliferative neoplasms
-
1:06
john mascarenhas, md, on the role of molecular analysis in myeloproliferative neoplasms
-
4:35
patient considerations that impact mpn treatment decisions
-
4:04
which tests do you need following an mpn diagnosis?
-
1:37
dr. mascarenhas on the potential role of pacritinib in mpns
-
2:59
how do mpns progress from one disease to the next?
-
4:53
what questions should patients ask about mpn test results?
-
3:07
do we need new endpoints to assess spleen response in mpn?
-
1:38
dr. mascarenhas on the need to develop curative therapies in myelofibrosis
-
2:22
what are the benefits of mpn inhibitor treatment?